Panacea Biotec Ltd - Company Profile
Powered by 
All the data and insights you need on Panacea Biotec Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Panacea Biotec Ltd Strategy Report
- Understand Panacea Biotec Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Panacea Biotec Ltd (Panacea) is a research-based health management company that research, develops, manufactures, distributes and markets pharmaceuticals, vaccines and biosimilars. Its vaccines portfolio includes trivalent and bivalent oral polio vaccine, and vaccines for diphtheria, tetanus, pertussis, Hepatitis B and haemophilus influenzae Type B. Its pharmaceutical formulations span across therapeutic areas, including oncology, nephrology, orthopedics, gastroenterology, pain management, diabetes, blood-related and organ transplantation, among others. The company also offers contract research and manufacturing services. Panacea operates manufacturing facilities in Baddi, Himachal Pradesh and Lalru, Punjab. It has presence in India, Switzerland, and Germany. Panacea is headquartered in New Delhi, India.
Headquarters
India
Address
B-1 Extn / G-3, Mathura Road, Mohan Co-Opindlestate, New Delhi, 110044
Website
www.panaceabiotec.com
Telephone
91 11 41679000
No of Employees
1,093
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
PANACEABIO (NSE)
Revenue (2022)
$58.6M
-30.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-103.1%
(2022 vs 2021)
Market Cap*
$101.5M
Net Profit Margin (2022)
XYZ
-104.4%
(2022 vs 2021)
* As of and is in US$
Panacea Biotec Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| - | Contract Research and Manufacturing Services | Pharmaceutical Formulations: |
| Therapeutic Categories: | Transplantation: | |
| Anti-Cancer | PanGraf (Tacrolimus) | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Plans/Strategy | In March, the company introduced new facility at Biocon Park, Bengaluru. |
| 2020 | Contracts/Agreements | In June, the company and Refana Inc entered into collaboration for the development, manufacturing and distribution of the Covid-19 vaccine across the world. |
| 2019 | Contracts/Agreements | In December, the company received a contract from UNICEF and PAHO, for the supply of Easyfive-TT, a fully liquid pentavalent vaccine. |
Competitor Comparison
| Key Parameters | Panacea Biotec Ltd | Zydus Lifesciences Ltd | Lupin Ltd | GlaxoSmithKline Pharmaceuticals Ltd | Dalas Biotech |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | New Delhi | Ahmedabad | Mumbai | Mumbai | Alwar |
| State/Province | Delhi | Gujarat | Maharashtra | Maharashtra | Rajasthan |
| No. of Employees | 1,093 | 23,026 | 18,971 | 3,680 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Rajesh Jain | Chairman; Managing Director | Executive Board | 2022 | - |
| Sandeep Jain | Joint Managing Director; Director | Executive Board | 1984 | - |
| Ankesh Jain | Director - Sales & Marketing; Director | Executive Board | 2016 | - |
| Rajeeva Kumar Mangalum | Chief Operating Officer | Senior Management | - | - |
| Syed Khalid | Chief Scientific Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer